KR101943230B1 - 항암제로서 라파마이신 및 알부민을 포함하는 나노입자 - Google Patents

항암제로서 라파마이신 및 알부민을 포함하는 나노입자 Download PDF

Info

Publication number
KR101943230B1
KR101943230B1 KR1020177002049A KR20177002049A KR101943230B1 KR 101943230 B1 KR101943230 B1 KR 101943230B1 KR 1020177002049 A KR1020177002049 A KR 1020177002049A KR 20177002049 A KR20177002049 A KR 20177002049A KR 101943230 B1 KR101943230 B1 KR 101943230B1
Authority
KR
South Korea
Prior art keywords
rapamycin
cancer
embodiments
mg
composition
Prior art date
Application number
KR1020177002049A
Other languages
English (en)
Other versions
KR20170014007A (ko
Inventor
네일 피. 드세이
패트릭 순-시옹
부옹 트리유
Original Assignee
아브락시스 바이오사이언스, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US60/905,669 priority Critical
Priority to US60/905,735 priority
Priority to US90576707P priority
Priority to US90575007P priority
Priority to US90573507P priority
Priority to US90566307P priority
Priority to US90566207P priority
Priority to US90566907P priority
Priority to US90573407P priority
Priority to US90567207P priority
Priority to US90578707P priority
Priority to US60/905,750 priority
Priority to US60/905,672 priority
Priority to US60/905,787 priority
Priority to US60/905,734 priority
Priority to US60/905,663 priority
Priority to US60/905,662 priority
Priority to US60/905,767 priority
Priority to US60/923,456 priority
Priority to US60/923,248 priority
Priority to US92324807P priority
Priority to US92345607P priority
Application filed by 아브락시스 바이오사이언스, 엘엘씨 filed Critical 아브락시스 바이오사이언스, 엘엘씨
Priority to PCT/US2008/003096 priority patent/WO2008109163A1/en
Publication of KR20170014007A publication Critical patent/KR20170014007A/ko
Application granted granted Critical
Publication of KR101943230B1 publication Critical patent/KR101943230B1/ko

Links